全球支原體測試市場規模、佔有率、成長分析，依應用（細胞株測試、病毒測試）、最終用途（學術研究機構、細胞庫）- 2024-2031 年產業預測

Global Mycoplasma Testing Market Size, Share, Growth Analysis, By Application(Cell Line Testing, Virus Testing), By End-Use(Academic Research Institutes, Cell Banks) - Industry Forecast 2024-2031

出版日期: 2024年04月12日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球支原體檢測市場規模為2.9891億美元，預計將從2023年的3.4076億美元成長到2031年的9.7204億美元，在預測期內（2024-2031年）複合年成長率為14%。

提供可靠、準確、有效的儀器和服務來識別和避免多種情況下的支原體污染是支原體檢測市場的目標。該市場包括各種商品，例如儀器、軟體、試劑、套件和測試，以及包括諮詢、測試和驗證在內的實驗室服務。支原體檢測市場服務於生物技術、製藥、學術研究和臨床診斷等眾多行業。支原體檢測市場受到多種原因的推動，例如對細胞療法和生物製藥的需求不斷成長、人們對支原體污染的潛在危害和影響的認知不斷增強，以及支原體檢測複雜技術和平台的引入。此外，由於支原體檢測監管標準和規範的收緊和標準化，對更可靠、更有效的檢測解決方案的需求日益成長。支原體檢測市場也受到許多變數的限制，包括檢測商品和服務的高價格、檢測方案缺乏統一和一致性，以及支原體檢測基礎設施和合格勞動力的稀缺。支原體檢測市場還必須應對許多障礙，包括需要不斷創新和增強檢測產品和服務，以滿足不斷變化的消費者和監管需求。此外，市場還必須解決與其他污染物交叉反應、假陽性和假陰性結果以及支原體菌株遺傳變異和適應的可能性等問題。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名玩家比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Merck KGaA (Germany)
Thermo Fisher Scientific Inc. (US)
Lonza Group Ltd. (Switzerland)
Sartorius AG (Germany)
PromoCell GmbH (Germany)
American Type Culture Collection (ATCC) (US)
Agilent Technologies, Inc. (US)
Bionique Testing Laboratories, Inc. (US)
Biological Industries Israel Beit Haemek Ltd. (Israel)
Charles River Laboratories International, Inc. (US)
Creative Bioarray (US)
InvivoGen (US)
Minerva Biolabs GmbH (Germany)
Biological Industries US, Inc. (US)
Norgen Biotek Corp. (Canada)
Novacyt Group (UK)
Mycoplasma Experience (France)
Genscript Biotech Corporation (China)
GeneCopoeia, Inc. (US)
Jena Bioscience GmbH (Germany)

簡介目錄

Product Code: SQMIG35I2219

Global Mycoplasma Testing Market size was valued at USD 298.91 million in 2022 and is poised to grow from USD 340.76 million in 2023 to USD 972.04 million by 2031, growing at a CAGR of 14% during the forecast period (2024-2031).

Providing dependable, accurate, and effective instruments and services for identifying and averting Mycoplasma contamination in many contexts is the aim of the mycoplasma testing market. The market includes a wide range of goods, such as instruments, software, reagents, kits, and testing, in addition to laboratory services including consulting, testing, and validation. Numerous industries, including biotechnology, pharmaceuticals, academic research, and clinical diagnostics, are served by the mycoplasma testing market. The market for mycoplasma testing is propelled by multiple causes, such as the escalating need for cell-based therapies and biopharmaceuticals, the expanding consciousness about the potential hazards and repercussions of mycoplasma contamination, and the introduction of sophisticated technologies and platforms for mycoplasma testing. Furthermore, there is a growing need for more reliable and effective testing solutions due to the tightening and standardization of regulatory criteria and norms around mycoplasma testing. The market for mycoplasma testing is also constrained by a number of variables, including the high price of testing goods and services, the lack of harmonization and consistency in testing protocols, and the scarcity of infrastructure and qualified labor for mycoplasma testing. The market for mycoplasma testing also has to contend with a number of obstacles, including the requirement for ongoing innovation and enhancement of testing goods and services in order to meet changing consumer and regulatory demands. Additionally, the market must deal with the problems of cross-reactivity with other pollutants, false-positive and false-negative results, and the possibility of genetic variability and adaptation of mycoplasma strains.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mycoplasma Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mycoplasma Testing Market Segmental Analysis

The global mycoplasma testing market is segmented on the application, end-use and region. By application, the market is segmented into cell line testing, virus testing, end of production cells testing, others. By end-use, the market is segmented into academic research institutes, cell banks, contract research organizations, pharmaceutical & biotechnology companies, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Mycoplasma Testing Market

The market for Mycoplasma testing is being driven by the increasing need for cell-based treatments and biopharmaceuticals. To guarantee the safety and effectiveness of these products and therapies, premium cells free of Mycoplasma contamination are needed.

Restraints in the Global Mycoplasma Testing Market

Many clients may find the high expense of mycoplasma testing goods and services to be a major deterrent, particularly in developing nations or environments with limited resources. The type of test utilized, the sample's complexity, and the test's sensitivity and specificity can all affect how much a mycoplasma test costs. Certain sophisticated testing techniques, such high-throughput sequencing or PCR-based assays, can be quite costly, rendering them unaffordable for certain clients.

Market Trends of the Global Mycoplasma Testing Market

Modern platforms and technologies, like PCR-based assays, flow cytometry, and nucleic acid sequencing, are emerging in the mycoplasma testing sector. These tools provide improved speed, sensitivity, and specificity over the conventional culture-based approaches.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Mycoplasma Testing Market by Application

Market Overview
Cell Line Testing
Virus Testing
End of Production Cells Testing
and Others

Global Mycoplasma Testing Market by End-Use

Market Overview
Academic Research Institutes
Cell Banks
Contract Research Organizations
Pharmaceutical & Biotechnology Companies
and Others

Global Mycoplasma Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PromoCell GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
American Type Culture Collection (ATCC) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bionique Testing Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biological Industries Israel Beit Haemek Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Bioarray (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InvivoGen (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Minerva Biolabs GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biological Industries US, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norgen Biotek Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novacyt Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mycoplasma Experience (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneCopoeia, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jena Bioscience GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments